YOLFTbeta
Biofrontera AG

Biofrontera AG

B8FK · XETRA · Healthcare / Drug Manufacturers - Specialty & Generic

2.77EUR-0.23 (-7.67%)

Price History

Full chart

Market Stats

Previous Close3.00
Open2.90
Day Range2.77 – 2.98
52-Week Range2.21 – 5.10
Volume1.44K
Market Cap22.36M
P/E (TTM)0.00
Forward P/E5000.00
EPS-1.09
Dividend Yield0.00%
Beta-0.23
50-Day Avg2.65
200-Day Avg2.53

About

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products and medical products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally. The company offers Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also provides RhodoLED XL lamp for the treatment of multiple interspersed lesions; and Belixos, a cosmetic product for irritated and sensitive skin. In addition, the company focus on photodynamic therapy (PDT) for the treatment of actinic keratosis and keratinocyte skin cancers, including basal cell carcinoma. The company has a license and supply agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Pilar de la Huerta Martinez
  • Employees73
  • HeadquartersHemmelrather Weg 201, Leverkusen, Germany, 51377, Germany
  • Websitehttps://www.biofrontera.com

Leadership

  • Ms. Pilar de la Huerta MartinezCFO & Member of Executive Board · b. 1969
  • Mr. Alexander RichardsonHead of UK Sales Team
  • Dr. Matthias NaumannHead of Sales & Marketing - Europe
  • Dr. Montserrat Foguet Ph.D.Managing Director of Biofrontera UK Ltd.

Financials

Income Statement

Currency: EUR2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue148.00K139.00K351.00K336.32K405.88K515.30K3.43M3.11M3.10M4.14M6.13M12.03M21.11M31.27M30.35M28.79M25.74M32.25M12.18M13.19M
Growth (%)--6.08%+152.52%-4.18%+20.68%+26.96%+565.90%-9.23%-0.61%+33.67%+48.15%+96.16%+75.53%+48.13%-2.94%-5.14%-10.59%+25.30%-62.22%+8.26%
Cost of Revenue632.00K691.00K581.00K5.98K170.64K444.88K1.51M1.60M1.12M1.24M1.65M1.72M4.45M4.88M3.54M3.91M4.76M6.88M2.07M2.28M
Gross Profit-484.00K-552.00K-230.00K330.34K235.24K70.41K1.92M1.51M1.98M2.90M4.48M10.31M16.66M26.39M26.81M24.87M20.98M25.37M10.12M10.91M
Gross Margin-327.03%-397.12%-65.53%98.22%57.96%13.66%56.05%48.51%63.93%70.14%73.05%85.74%78.91%84.41%88.35%86.41%81.52%78.67%83.03%82.71%
Operating Expense3.97M5.46M8.29M5.77M6.35M4.44M5.48M8.65M11.51M13.13M16.26M24.24M35.13M49.77M32.42M60.21M19.39M20.59M11.70M11.93M
Operating Income-4.46M-6.01M-8.52M-5.44M-6.12M-4.37M-3.55M-7.14M-9.53M-10.23M-11.78M-13.93M-18.48M-23.38M-5.61M-35.34M1.59M4.78M-1.59M-1.02M
Operating Margin-3011.49%-4326.62%-2427.07%-1617.32%-1507.43%-848.80%-103.54%-229.17%-307.76%-247.25%-192.14%-115.88%-87.54%-74.77%-18.49%-122.76%6.18%14.83%-13.03%-7.77%
EBITDA-3.92M-5.45M-7.99M-4.88M-5.80M-4.01M-2.91M-6.40M-7.85M-9.15M-10.12M-14.09M-16.73M-20.22M-277.00K-12.59M2.34M5.57M-301.00K-560.00K
EBITDA Margin-2647.97%-3919.42%-2277.49%-1452.36%-1429.22%-778.58%-84.79%-205.35%-253.47%-221.23%-165.11%-117.13%-79.27%-64.68%-0.91%-43.74%9.08%17.28%-2.47%-4.25%
Net Income-7.89M-8.01M-15.09M-3.43M-7.66M-4.64M-4.12M-8.07M-10.72M-11.20M-10.58M-16.10M-8.88M-7.36M-13.02M37.75M-44.17M-369.00K-4.35M-3.96M
Net Income Margin-5332.43%-5759.71%-4298.29%-1018.44%-1886.52%-901.21%-120.01%-259.00%-346.33%-270.75%-172.57%-133.90%-42.06%-23.53%-42.92%131.13%-171.60%-1.14%-35.71%-30.06%
R&D2.19M2.99M5.90M3.40M3.65M1.40M1.38M3.19M4.53M6.20M4.64M4.22M4.43M4.64M4.79M7.01M7.13M7.85M2.20M2.23M
R&D as % of Total Revenue1481.08%2149.64%1682.05%1011.22%898.44%271.84%40.34%102.30%146.47%149.93%75.70%35.14%20.97%14.83%15.78%24.35%27.69%24.33%18.04%16.92%
Interest Expense2.46M1.94M6.80M377.00K1.54M270.09K550.16K928.88K1.29M1.17M1.21M1.13M1.78M2.71M3.08M3.72M163.00K15.00K11.00K14.00K
Interest Expense % of Total Revenue1664.86%1394.24%1937.32%112.10%379.09%52.41%16.03%29.82%41.66%28.24%19.69%9.42%8.45%8.67%10.15%12.92%0.63%0.05%0.09%0.11%

Balance Sheet

Currency: EUR2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets16.40M11.79M3.75M3.37M2.57M5.70M9.04M9.64M14.01M9.50M23.88M19.85M39.13M58.36M56.39M76.13M32.73M30.73M30.15M20.64M
Total Liabilities17.08M17.97M23.83M13.74M15.46M18.23M13.13M14.18M14.03M14.31M8.04M16.47M22.78M48.41M49.02M18.70M12.39M10.75M11.30M5.80M
Total Equity-826.00K-6.19M-20.09M-10.37M-12.89M-12.53M-4.09M-4.55M-21.00K-4.81M15.84M3.38M16.36M9.96M7.38M57.43M20.34M19.98M18.86M14.90M
Cash---1.41M692.14K553.57K3.37M2.93M8.51M3.96M15.13M11.08M19.45M11.12M16.55M6.91M6.38M3.08M3.12M3.60M
Total Debt15.40M16.46M21.20M65.74K12.71M15.96M11.66M12.50M12.00M12.07M3.88M12.53M13.63M23.32M23.88M3.30M1.50M1.15M765.00K626.00K
Net Debt15.40M16.46M21.20M-1.34M12.02M15.41M8.29M9.56M3.49M8.11M-11.25M1.44M-5.82M12.20M7.33M-3.61M-4.88M-1.93M-2.36M-2.98M

Cash Flow

Currency: EUR2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-7.32M-7.63M-13.40M-3.67M-5.63M-4.67M-5.17M-7.66M-7.93M-9.72M-10.74M-13.12M-13.43M-32.89M-2.85M30.44M-3.90M-1.92M-2.54M-4.40M
Investing Cash Flow1.13M-2.13M3.06M446.14K-35.13K-291.20K-138.30K-322.95K78.87K17.03K-455.31K-375.00K-511.00K21.05M2.87M-42.26M-981.00K-912.00K-210.00K5.33M
Financing Cash Flow4.48M3.86M5.67M4.48M4.94M4.82M8.13M7.56M13.42M5.15M22.36M9.45M22.27M3.46M5.95M2.18M4.34M-467.00K2.79M-452.00K
Capital Expenditure94.10K344.70K240.31K14.31K73.52K305.83K171.97K341.98K164.08K180.30K484.54K397.00K513.00K1.85M774.00K629.00K981.00K912.00K210.00K51.00K
Free Cash Flow-7.42M-7.97M-13.64M-3.68M-5.70M-4.98M-5.35M-8.01M-8.09M-9.90M-11.22M-13.52M-13.95M-34.75M-3.62M29.81M-4.88M-2.83M-2.75M-4.45M
FCF to OCF101.28%104.52%101.79%100.39%101.31%106.55%103.32%104.46%102.07%101.86%104.51%103.03%103.82%105.64%127.17%97.93%125.19%147.57%108.27%101.16%

Earnings

Report DateMar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017May 30, 2018Aug 31, 2018Nov 16, 2018Apr 29, 2019Aug 27, 2019Nov 19, 2019Apr 21, 2020Aug 27, 2020Jan 5, 2021May 11, 2021Aug 19, 2021Nov 18, 2021May 17, 2022Aug 18, 2022Nov 16, 2022May 31, 2023Aug 31, 2023Nov 15, 2023May 31, 2024Sep 30, 2024Nov 29, 2024Jun 2, 2025Sep 30, 2025Nov 28, 2025Jun 3, 2026
EPS Estimate----------------2.31-1.89--1.57-2.10-3.15-1.26-0.63--2.52-1.89-1.89-------------
EPS Actual-1.36-1.31-1.20-1.30-1.11-2.30-0.87-0.81-0.17-1.08-1.32-1.19-0.86-1.27-1.43-1.68-2.10-1.161.685.25-5.46-2.100.42-1.64-1.89-1.47-2.10-5.78-1.78-1.05-0.660.06-0.60-0.52-0.43-0.150.32-0.72-0.060.36
Surprise---------------27.27%-11.11%-207.01%350.00%-73.33%-66.67%166.67%-25.00%22.22%-11.11%-------------
Timing---------------Pre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-market-------Pre-market-After-hoursAfter-hours--

Key Statistics & Ratios

Market Cap22.36M
Enterprise Value11.75M
Trailing P/E0.00
Forward P/E5000.00
Price / Sales1.40
Price / Book0.95
EPS-1.09
Book Value3.37
Revenue (TTM)15.96M
Gross Profit (TTM)12.94M
EBITDA2.07M
Profit Margin32.95%
Operating Margin26.88%
Return on Equity-36.44%
Return on Assets-1.96%
Shares Outstanding6.08M
Shares Float1.39M
Beta-0.23
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 14, 20241:21